Researchers created NeuroBridge, an AI tool that shows how autistic and non-autistic people can interpret speech differently. The tool gives example replies and trains clearer, more direct communication based on autistic preferences.
Photo by Peter Burdon, Unsplash
Researchers at the University of Missouri tested the FDA-approved CanvasDx, an AI device, to help primary care evaluate autism where specialty centres are far away. In a study it gave determinate results for 52% of 80 children and matched clinicians' diagnoses.
A study in The American Journal of Psychiatry found lower availability of a glutamate receptor called mGlu5 across the brains of autistic adults. Researchers used PET, MRI and EEG and say the result could affect future diagnosis and treatment.
No more articles